Last Week’s Hot Topic on Pulmonary Fibrosis
Last week’s hot topic on pulmonary fibrosis was IPF Drug in Phase 2 Study Reduced Lung Fibrosis, Improved Function in 35% of Patients written by Margarida Azevedo. FibroGen, Inc., recently disclosed potentially groundbreaking results from a Phase 2 clinical trial evaluating the efficacy of the company’s…